Literature DB >> 1951086

Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group.

S Singh1, R K Saini, J DiMarco, J Kluger, R Gold, Y W Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951086     DOI: 10.1016/0002-9149(91)90200-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

1.  Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study.

Authors:  T Levy; S Walker; M Mason; P Spurrell; S Rex; S Brant; V Paul
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 2.  Potentially significant drug interactions of class III antiarrhythmic drugs.

Authors:  Weeranuj Yamreudeewong; Michael DeBisschop; Linda G Martin; Dennis L Lower
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival.

Authors:  Shaan Khurshid; Simon Akerman; Jonathan P Man; Gregory Supple; Sanjay Dixit; Andrew E Epstein; Francis E Marchlinski; David S Frankel
Journal:  J Interv Card Electrophysiol       Date:  2015-01-27       Impact factor: 1.900

Review 4.  Atrial Fibrillation Complicating Congestive Heart Failure: Electrophysiological Aspects And Its Deleterious Effect On Cardiac Resynchronization Therapy.

Authors:  Osmar Antonio Centurión
Journal:  J Atr Fibrillation       Date:  2009-06-01

5.  Initial experience with single lead intracardial cardioversion for refractory atrial fibrillation.

Authors:  H A van de Klippe; C P Allaart; J H Ruiter
Journal:  Neth Heart J       Date:  2001-09       Impact factor: 2.380

6.  Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.

Authors:  G Nichol; F McAlister; B Pham; A Laupacis; B Shea; M Green; A Tang; G Wells
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 7.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.

Authors:  James V Freeman; Kristi Reynolds; Margaret Fang; Natalia Udaltsova; Anthony Steimle; Niela K Pomernacki; Leila H Borowsky; Teresa N Harrison; Daniel E Singer; Alan S Go
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-20

Review 9.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.